Ann: Zeldas Phase II Insomnia Clinical Trial Fully Enrolled, page-19

I was on the conference call too, and I don’t think Harry said “good” or “positive” results straight out, but did add the fact that they didn’t know yet because it’s double blinded, so if you read between the lines, maybe you can draw the conclusion that he is super confident about the upcoming report, but nothing definitely conclusive just yet.

With the announcement yesterday where it mentioned so serious adverse effects have been reported so far, should answer your question that the trial began a while back and the last patient is due to complete their dosing by late 2019 with an announcement next Feb.

In my opinion this is going to be a great merger with Ilera to immediately distribute the products once the trial is complete (if it’s positive... but would they really make that move if they didn’t think they’d have a good chance?).